JPRN-UMIN000027281已完成未知
Evaluation of pharmacist intervention for inhalation therapy in patients with chronic obstructive pulmonary disease (COPD) and asthma. - Evaluation of pharmacist intervention for inhalation therapy
School of pharmacy, Showa University0 个研究点目标入组 60 人开始时间: 2017年5月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients are excluded if they have cancer, sever liver or renal dysfunction, and difficulty of inhaling by themselves.
研究者
相似试验
已完成
不适用
Evaluation of Pharmacist Intervention for improving Adherence of Immunosuppressive Regimen in Kidney Transplant RecipientsKidney Transplant.Kidney transplant statusZ94.0IRCT20150706023084N9Islamic Azad University, Pharmaceutical Sciences Branch50
已完成
不适用
Effectiveness of a pharmacist intervention in patients with lung diseaseChronic Obstructive Pulmonary Disease (COPD)RespiratoryChronic obstructive pulmonary disease, unspecifiedISRCTN32281812The Health Research Foundation200
招募中
Unknown
Outcome Measure of Pharmacist-led Intervention for Chronic Kidney Disease PatientsChronic kidney diseaseJPRN-UMIN000049914Kinjo Gakuin University50
已完成
不适用
Evaluation of Pharmacists Intervention for the prevention of occurrence of kidney toxicity during vancomycin usagekidney toxicity on using vancomycinJPRN-UMIN000015255TBD600
尚未招募
Unknown
Efficacy of pharmacist intervention for a patient who takes incretin modulator.Diabetes mellitusJPRN-UMIN000050659Chiba Pharmaceutical Association60